stockrow
Saturday 7 November 2026
Export VERU’s income statement to Excel — free account
Veru Inc.
VERU Healthcare Biotechnology
Veru Inc.’s revenue for fiscal 2024 (year ended September 2024) was $16.9 million, up 3.62% from fiscal 2023.
- EPS
- +40.0%
- Free cash flow
- +0.27%
Quarter to June 2026, against a year earlier
2.14
0.08
+3.88%
Follow VERU
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
4.19 | 5.71 | 4.97 | 2.35 | |
Current Ratio |
4.42 | 6.19 | 5.16 | 2.43 | |
Net Debt/EBITDA |
3.36 | 4.28 | 6.56 | (15.33) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 3.25 | 1.16 | (3.78) | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.19 | 0.16 | 0.14 | 0.23 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.24) | (0.39) | (0.30) | (0.37) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.24) | (0.39) | (0.30) | (0.37) | |
Cash per Share |
1.12 | 1.33 | 1.74 | 1.25 | |
Shareholders Equity per Share |
1.23 | 1.51 | 1.83 | 1.25 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.23 | 1.51 | 1.83 | 1.25 | |
Free Cash Flow |
(5.47) | (8.91) | (6.17) | (5.49) | |
Working Capital |
21.07 | 27.97 | 29.68 | 11.13 | |
Capital Expenditures |
— | — | — | 0.00 | |
Net Current Asset Value |
18.58 | 25.06 | 26.36 | 7.41 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | — | 0.00 | |
| Other line items | |||||
Average Payables |
2.12 | 2.14 | 1.76 | 2.69 | |
Average Assets |
32.18 | 37.88 | 43.70 | 45.13 | |
Average Common Equity |
21.86 | 27.92 | 31.88 | 25.32 |
Columns are period end dates · fundamentals updated 26 Oct 2026